CNC machined parts for medical devices are inspected against the controlled drawing and purchase specification in a risk-based plan covering identity, material records, dimensions and geometry, surfaces and edges, cleanliness, final processing, packaging, and release documents. Methods and sampling depend on feature criticality, material, production stage, lot, final condition, and device risk; no universal medical checklist applies. Buyers should put critical characteristics, records, and release ownership in the request for quotation (RFQ).
Release begins by confirming part number, drawing revision, lot, and process state. Computer numerical control (CNC) machine data does not prove conformity. A micrometer, gauge, profilometer, or coordinate measuring machine (CMM) must match the characteristic and decision rule. Guidance on quality control in CNC machining and ISO-certified CMM quality assurance supports planning, but the released drawing and purchase order control acceptance.
Dimensional and geometric inspection verifies critical bores, fits, threads, position, profile, runout, and datum faces tied to function. Micrometers and bore gauges measure size, thread gauges check limits, height gauges establish face relationships, and a CMM evaluates defined geometry. Instrument resolution alone does not establish an adequate method.
Inspect after grinding, coating, passivation, polishing, deburring, or any operation that can change the feature. The plan should identify datum setup, method, calibration status, sampling or 100-percent requirement, and result record. Use a functional gauge or mating check when separate measurements cannot represent the assembly stack.
Pre-Delivery Check | Main Purpose | Why It Matters for Medical Parts |
|---|---|---|
Dimensional inspection | Verify size, position, profile, runout, threads, and datum relationships | Protects functional assembly; record the method, final condition, and result |
Surface inspection | Check specified texture, burr limits, scratches, damage, and edge condition | Protects contact and handling surfaces; use defined acceptance criteria |
Cleaning verification | Confirm specified particle, residue, visual, or chemical cleanliness evidence | Prevents hidden contamination; clean does not automatically mean sterile |
Packaging control | Preserve the approved part state, identity, and lot separation | Prevents damage, mixing, corrosion, or recontamination during delivery |
Document confirmation | Reconcile drawing revision, lot, material, process, inspection, and release records | Links the shipped quantity to the evidence required by the order |
Surface inspection checks specified texture, scratches, tool marks, discoloration, finish condition, and functional-face damage. Edge inspection targets burrs, rollover, sharp edges, drilled exits, cross-holes, threads, and seal lands. A visual statement cannot replace a drawing limit, profilometer method, magnification, or functional criterion.
Review surfaces after the last altering operation and under agreed lighting, magnification, direction, or roughness conditions. A sealing-face scratch, rounded datum edge, or internal burr can make a dimensionally conforming part unfit. Record nonconformance and disposition instead of polishing away an unapproved defect.
Cleaning verification confirms that the specified process removed chips, cutting fluid, polishing compound, salts, fingerprints, and residues from external and internal features. Blind holes, threads, slots, and intersecting passages need special attention because exterior inspection cannot prove their condition. Rinsing, drying, handling, and packaging must prevent recontamination.
Acceptance may use magnified inspection, particle limits, nonvolatile residue, chemical testing, or documented extraction, depending on specification and risk. The methods are not interchangeable. Clean is not sterile, so the RFQ must assign cleaning validation, sterilization, sterile-barrier, and packaging responsibilities.
Packaging control preserves the approved state through storage and transport. It should prevent contact damage, abrasion, corrosion, mixed lots, label loss, deformation, and recontamination. Trays, separators, bags, caps, or protectors depend on geometry, surface, material, cleanliness, quantity, and route.
Final packaging inspection checks count, lot identity, label and revision, specified barrier integrity, and critical-feature protection. Packaging is not a validated sterile barrier unless requirement, method, and ownership are defined. The release record should identify the shipped configuration.
Release Risk | How Suppliers Control It Before Delivery |
|---|---|
Wrong dimensions | Use the controlled revision, matching datum setup, suitable calibrated method, and recorded result |
Surface damage or burrs | Inspect specified texture, edges, passages, and contact areas after the final surface operation |
Residual contamination | Apply the agreed cleanliness method to high-risk external and internal features |
Transport damage | Verify the approved packaging configuration, separation, labeling, and critical-feature protection |
Document mismatch | Reconcile lot, quantity, drawing, material, process, inspection, deviation, and release records |
Document confirmation links the shipped lot to required evidence. The purchase order may require dimensional reports, material certificates, special-process or cleaning records, first-article data, deviations, and lot identity. Not every part needs every document; the contract defines the set.
Records should show the released part and revision, inspected quantity or sample, and acceptance status. Open nonconformances need approved disposition before shipment. A generic certificate cannot replace characteristic-level or process evidence required by the order.
Inspection scope follows feature criticality, prototype or validation needs, process maturity, lot size, supplier history, and device risk controls. Prototypes may need broad reports; repeat production may sample stable noncritical characteristics. Critical features are not automatically suitable for reduced sampling.
ISO 2859-1 can support contract-selected attribute sampling; it does not assign a universal medical level. ISO 14253-1 can support an agreed conformity decision near a limit. Define 100-percent checks, sampling, retention, and reaction rules before production.
Useful evidence connects drawing revision, datum strategy, measurement method, final processing, cleanliness, packaging, and lot records. A claim that "everything is inspected" gives no sourcing basis. Review a representative report, method list, sample plan, nonconformance workflow, and release responsibility during qualification.
Confirm which requirements belong to the machining supplier and which remain with the device owner or assembler. The boundary may include biological evaluation, cleaning validation, sterilization, sterile packaging, and device-level testing. Clear ownership prevents an inspection report from being mistaken for device approval.
CNC machined parts for medical devices are released through risk-based checks of identity, controlled requirements, dimensions and geometry, surfaces and edges, cleanliness, final processing, packaging, and documents. Sequence, method, and sampling depend on function, process stage, final condition, purchase requirements, and device risk; visual review alone is not a release plan.
Before ordering, define critical features, datums, final-state checks, cleanliness evidence, sampling, records, packaging, and release ownership. Structured quality control, a clear medical-device responsibility boundary, and controlled CNC machining records let a buyer verify the lot instead of relying on a general promise.